Lixisenatide
| Autor: | Baker, Danial E., Levien, Terri L. |
|---|---|
| Rok vydání: | 2017 |
| Předmět: | |
| Zdroj: | Hospital Pharmacy. 52:65-80 |
| ISSN: | 1945-1253 0018-5787 |
| DOI: | 10.1310/hpj5201-65 |
| Popis: | Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The January 2017 monograph topics are bezlotoxumab, buprenorphine buccal, defazacort, dupilumab, and olaratumab. The DUE is on buprenorphine buccal. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|